Jacobus

Jacobus is inviting 30 selected individuals with Lambert-Eaton myasthenic syndrome to participate in a placebo-controlled trial of 3,4-DAP

posted on January 25, 2012 - 6:00am
Update (Oct.

New content is being added every day. Please check back again.